Cardiology Societies Urge Registry For Left-Atrial Appendage Closure Devices
This article was originally published in The Gray Sheet
Executive Summary
The American College of Cardiology, Heart Rhythm Society, and Society for Cardiovascular Angiography and Interventions released an overview of left atrial appendage occlusion devices, specifically Boston Scientific's Watchman and SentreHEART's Lariat.
You may also be interested in...
LAA Closure Devices: Cardiology Societies Weigh In
In June 2015, three cardiology societies issued a clinical overview on implantation of left atrial appendage closure devices that is the first in a series of documents highlighting the critical issues that need to be addressed in order to integrate these new technologies into clinical practice.
Policy Briefs: What's New From FDA And CMS
Updates include an FDA safety communication for the Lariat suture device addressing use for left atrial appendage closure, new FDA draft guidance documents, and CMS proposals to cut radiation therapy payments and launch new payment models for hip and knee replacements.
National Medicare Analysis Opened For Watchman Device
CMS will consider a national policy for the left atrial appendage closure device in response to a request from Boston Scientific.